240 related articles for article (PubMed ID: 25340929)
1. Drug disposition in obesity: toward evidence-based dosing.
Knibbe CA; Brill MJ; van Rongen A; Diepstraten J; van der Graaf PH; Danhof M
Annu Rev Pharmacol Toxicol; 2015; 55():149-67. PubMed ID: 25340929
[TBL] [Abstract][Full Text] [Related]
2. The effects of obesity on drug pharmacokinetics in humans.
Morrish GA; Pai MP; Green B
Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):697-706. PubMed ID: 21417960
[TBL] [Abstract][Full Text] [Related]
3. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
[TBL] [Abstract][Full Text] [Related]
4. Perioperative pharmacology in morbid obesity.
Lemmens HJ
Curr Opin Anaesthesiol; 2010 Aug; 23(4):485-91. PubMed ID: 20531173
[TBL] [Abstract][Full Text] [Related]
5. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
6. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters.
Smit C; De Hoogd S; Brüggemann RJM; Knibbe CAJ
Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):275-285. PubMed ID: 29431542
[TBL] [Abstract][Full Text] [Related]
7. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
Mahmood I
Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
Kendrick JG; Carr RR; Ensom MH
Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
[TBL] [Abstract][Full Text] [Related]
9. Dosing dilemmas in obese children.
Mulla H; Johnson TN
Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Obesity on Drug Metabolism in Children.
Oeser SG; Rougee LR; Collier AC
Drug Metab Lett; 2015; 9(2):88-98. PubMed ID: 26411468
[TBL] [Abstract][Full Text] [Related]
11. Influence of obesity on drug disposition.
Blouin RA; Kolpek JH; Mann HJ
Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
[TBL] [Abstract][Full Text] [Related]
12. The effects of gastric bypass surgery on drug absorption and pharmacokinetics.
Brocks DR; Ben-Eltriki M; Gabr RQ; Padwal RS
Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1505-19. PubMed ID: 22998066
[TBL] [Abstract][Full Text] [Related]
13. Lean-scaled weight: a proposed weight scalar to calculate drug doses for obese patients.
Friesen JH
Can J Anaesth; 2013 Feb; 60(2):214-5. PubMed ID: 23192695
[No Abstract] [Full Text] [Related]
14. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
Morgan DJ; Bray KM
Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
[TBL] [Abstract][Full Text] [Related]
15. Impact of obesity on drug metabolism and elimination in adults and children.
Brill MJ; Diepstraten J; van Rongen A; van Kralingen S; van den Anker JN; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):277-304. PubMed ID: 22448619
[TBL] [Abstract][Full Text] [Related]
16. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
Schwartz JB
Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
[TBL] [Abstract][Full Text] [Related]
17. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
Polso AK; Lassiter JL; Nagel JL
J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
[TBL] [Abstract][Full Text] [Related]
18. Dosing in obesity: a simple solution to a big problem.
Han PY; Duffull SB; Kirkpatrick CM; Green B
Clin Pharmacol Ther; 2007 Nov; 82(5):505-8. PubMed ID: 17952107
[TBL] [Abstract][Full Text] [Related]
19. Individualizing the use of medications in children: making Goldilocks happy.
Leeder JS; Brown JT; Soden SE
Clin Pharmacol Ther; 2014 Sep; 96(3):304-6. PubMed ID: 24926777
[TBL] [Abstract][Full Text] [Related]
20. Oral bioavailability and first-pass effects.
Kwan KC
Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
